I lost two stone on Mounjaro, but then developed agonising stomach pains. I sought urgent medical care and discovered a little-known side effect that could have killed me. Here's what you must do now

✕ Sensationalism: The headline uses dramatic, fear-inducing language such as 'agonising stomach pains', 'could have killed me', and 'what you must do now' to provoke urgency and emotional reaction, typical of clickbait.

"I lost two stone on Mounjaro, but then developed agonising stomach pains. I sought urgent medical care and discovered a little-known side effect that could have killed me. Here's what you must do now"

✕ Appeal To Emotion: The headline leverages personal fear and parental concern to draw readers in, framing the story as a life-or-death warning rather than a balanced health report.

"could have killed me. Here's what you must do now"

✕ Loaded Language: The article uses emotionally charged terms like 'agonising', 'screamed', 'vomited with panic', and 'foolish decision' to dramatise the personal experience, blurring the line between news and confessional storytelling.

"I let out an ear-piercing scream, and was diagnosed with an inflamed gallbladder."

✕ Editorializing: The author injects personal judgment and regret into the narrative, such as calling their decision 'foolish', which introduces subjective opinion into a health reporting context.

"I had plenty of time to dwell on my foolish decision to resort to Mounjaro."

✕ Narrative Framing: The article is structured as a personal redemption arc — from hope to crisis to regret — which prioritises storytelling over objective reporting.

"I’d read so many positive stories of people whose bodies, lives even, had been transformed by the jabs. Naturally, I was very much looking forward to having this helping hand..."

✓ Proper Attribution: The article cites a named medical expert, surgeon Ahmed Ahmed, and references NHS England data, providing some credible sourcing.

"surgeon Ahmed Ahmed, president of the British Obesity and Metabolic Specialist Society, said this year that there appears to be a connection between use of the jabs and the risk of developing gallstones."

✓ Comprehensive Sourcing: It includes data from NHS England and mentions the manufacturer's (Eli Lilly) acknowledgment of gallbladder infection as a potential side effect, adding institutional credibility.

"Mounjaro manufacturer Eli Lilly now cites gallbladder infection as a potential, if uncommon, side-effect."

✕ Vague Attribution: The author claims 'more and more' patients report using GLP-1s before surgery, but this is attributed to a single surgeon’s observation without data or broader consensus.

"He reported that ‘more and more’ of those coming to him for gallbladder operations were saying they had used GLP-1 receptor agonists"

✕ Omission: The article fails to mention that gallbladder issues are a known risk with rapid weight loss regardless of method, not unique to GLP-1 drugs, which would provide crucial context.

✕ Cherry Picking: Focuses exclusively on negative outcomes without discussing the millions who use GLP-1s safely or the broader benefits in diabetes and obesity management.

"I can’t definitively prove the link in my case..."

✕ Misleading Context: Presents rising gallbladder surgery rates alongside rising GLP-1 use as suggestive of causation, without controlling for other factors or providing incidence rates.

"NHS England figures show that, between 2024 and 2游戏副本2025, at a time when the popularity of fat jabs was ballooning, the number of gallbladder surgeries was at its highest peak in a decade."